Regional News


(Portland, OR)  --  Oregon and Washington are named as potential beneficiaries in a federal lawsuit filed this week against drug companies that make insulin.  KGW-TV reports the lawsuit, representing all 50 states, accuses insulin manufacturers Sanofi, Novo Nordisk, and Eli Lilly of conspiring to raise prices, despite no alleged change in costs to produce the products.  President Donald Trump has noted that while drug companies have produced extraordinary results, prices have been astronomical.  Trump says he has plans to lower taxes and FDA regulations to provide incentive for pharmaceutical companies to reduce prices.

Hide Comments

Traffic

 

 

  • Click the link above to get the latest road conditions.

 

KBND ON FACEBOOK
 
FOLLOW US ON TWITTER
News Disclaimers